Lead Sponsor

Pfizer

Age

51 - No limit years

Sex

ALL

Healthy Volunteers

No

•Subject has completed study 3133K1-3000 and brain magnetic resonance imaging (MRI) scan consistent with the diagnosis of Alzheimer Disease
•Mini-Mental Status Examination (MMSE) \>=10 at screening
•Caregiver able to attend all clinic visits with subject

•Any medical or psychiatric contraindication or clinically significant abnormality that, in the investigator's judgment, will substantially increase the risk associated with the subject's participation in and completion of the study or could preclude the evaluation of the subject's response.
•Any significant brain MRI abnormality.
•Use of any investigational drugs or devices, other than bapineuzumab within the last 60 days prior to screening